Chronic Plaque Psoriasis Market is Expected to Grow at a Substantial Growth Rate Over the Forecast Period (2019-2032) | Key Companies – Arcutis, Dermavant Sciences, UCB, BMS, Merck, Pfizer, Boehringer

Delveinsight Business Research LLP

According to DelveInsight, the chronic plaque psoriasis market size is expected to increase in the coming years due to the increase in the prevalent population in 7MM. The launch of emerging therapies, ongoing research and development (R&D) activities, and the active participation of global pharmaceutical and biotech giants in the therapeutic segment will also influence the growth of the market.

by DelveInsight Chronic Plaque Psoriasis Market Overview, Epidemiology and Market Forecast 2032 The report provides an in-depth understanding of the disease, historical and forecasted epidemiology, and Chronic Plaque Psoriasis market size, share, and trends across the top seven (7MM) markets (i.e., i.e. USA, EU5 (Germany, Spain, Italy, France and UK) and Japan).

The chronic plaque psoriasis market the report covers emerging drugs, current treatment practices, individual therapies market share, and current and forecasted market size from 2019 to 2032. It also assesses current treatment practice/algorithm, drivers and market barriers and unmet medical needs. opportunities and assess the underlying market potential.

chronic plaque psoriasis market

Chronic Plaque Psoriasis: An Overview

Psoriasis is recognized as the most common immune-mediated inflammatory disease involving the skin and joints and is associated with abnormalities of other systems. Although the disease is not life-threatening, it is difficult to treat and response rates vary widely.

According to the National Psoriasis Foundation, about 80 to 90 percent of people with psoriasis have plaque psoriasis.

In recent years, several technologies have been developed to improve the efficacy and safety of topical drug therapy. Moreover, new drug carriers offer the possibility of introducing new molecules in the topical treatment of psoriasis. For these purposes, vesicular drug delivery systems including niosomes, proniosomes, liposomes, transferosomes, non-vesicular drug delivery systems such as foams, gels and nanoparticles have been developed. .

Key drivers of the Chronic Plaque Psoriasis Market

  • Delveinsight estimates that the total psoriasis patient population in the seven major markets was 15,450,700+ cases in 2020.

  • In 2020, the prevalence of plaque psoriasis in the United States turned out to be 6.6 million.

  • According to Dogra and Mahajan, chronic plaque psoriasis is the most common morphological presentation of psoriasis, accounting for more than 90% of all cases.

  • According to the World Health Organization (WHO), plaque psoriasis is the most common type of psoriasis and affects between 58% and 97% of all patients.

chronic plaque psoriasis market

The market outlook section of the report helps in building a detailed understanding of the historical, current and forecasted. Chronic Plaque Psoriasis Market Size by analyzing the impact of current and emerging therapies on the market. It also provides an in-depth assessment of market drivers and barriers, unmet needs, and emerging technologies.

The report details the Chronic Plaque Psoriasis Market Trend for each marketed drug and late-stage therapy by assessing their impact based on annual therapy cost, mechanism of action (MoA), competition with other therapies, brand value, and impact on the market.

Epidemiology of chronic plaque psoriasis

The epidemiology section provides an overview of historical, current and projected epidemiological trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and projected trends by exploring numerous studies and viewpoints from world leaders. key opinion. The epidemiology section also provides a detailed analysis of the pool of diagnosed patients and future trends.

Epidemiological segmentation of chronic plaque psoriasis

  • Prevalence of psoriasis (adults and children)

  • Prevalence of chronic plaque psoriasis by severity

  • Prevalence of chronic plaque psoriasis

  • Diagnosed and treatable cases of chronic plaque psoriasis

Chronic Plaque Psoriasis Drug Adoption and Pipeline Development Activities

The drug absorption section focuses on the absorption rate of potential drugs recently launched in the chronic plaque psoriasis market or should be launched during the study period. The analysis covers chronic plaque psoriasis market uptake by drugs, patient uptake of therapies, and sales of each drug.

In addition, the therapeutic evaluation section helps to understand which drugs are absorbed the fastest and the reasons for the maximum use of drugs. Moreover, it compares drugs based on their market share.

The report also covers the Chronic Plaque Psoriasis Pipeline Development Activities. It provides valuable information on different therapeutic candidates at various stages and on the main companies involved in the development of targeted therapies. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details and other information on emerging therapies.

Request for Sample PDF Report –

Therapeutic analysis of chronic plaque psoriasis

The chronic plaque psoriasis market dynamics are expected to change in the coming years owing to the growing awareness of the disease and better approaches to developing therapies globally.

Some of the Chronic Plaque Psoriasis Market Companies Include:

And many others

Chronic plaque psoriasis therapies covered in the report include:

And much more.

The planned launch of emerging therapies is expected to have a significant impact on the chronic plaque psoriasis treatment scenario in the coming years.

Get more in-depth insights on Emerging Therapies and Key Companies –

Table of Contents (TOC)

1. Key information

2. Executive Summary

3. Chronic Plaque Psoriasis Competitive Intelligence Analysis

4. Chronic Plaque Psoriasis Market Overview at a Glance

5. Background and Overview of Chronic Plaque Psoriasis Disease

6. Patient journey with chronic plaque psoriasis

7. Chronic plaque psoriasis epidemiology and patient population

8. Chronic plaque psoriasis treatment algorithm, current treatment and medical practices

9. Unmet Needs in Chronic Plaque Psoriasis

10. Key Parameters for the Treatment of Chronic Plaque Psoriasis

11. Products Marketed for Chronic Plaque Psoriasis

12. Emerging therapies for chronic plaque psoriasis

13. Chronic Plaque Psoriasis Seven Key Market Analysis

14. Attribute Analysis

15. Chronic Plaque Psoriasis Market Outlook (Major 7 Markets)

16. Chronic Plaque Psoriasis Access and Reimbursement Overview

17. KOL’s views on the chronic plaque psoriasis market.

18. Chronic Plaque Psoriasis Market Drivers

19. Chronic Plaque Psoriasis Market Barriers

20. Appendix

21. DelveInsight Abilities

22. Disclaimer

*The table of contents (TOC) is not exhaustive; final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

About DelveInsight
DelveInsight is a leading business consultant and market research firm focused exclusively on life sciences. It supports pharmaceutical companies by providing complete end-to-end solutions to improve their performance.

Other health trend reports by DelveInsight

Injectable Drug Delivery Devices Market
The research report on Injectable Drug Delivery Devices Market provides comprehensive information on historical and forecast market size, share, trends and growth estimation for Injectable Drug Delivery Devices. It also covers the latest breakthroughs, collaboration, latest innovations, emerging devices and key companies working in the global Injectable Drug Delivery Devices market.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact person: Anuj Rawat
E-mail: Send an email
Call: 9193216187
Address:304 S. Jones Boulevard #2432
Town: Albany
State: New York
Country: United States